Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | International

USA. Research Summary: Buprenorphine Diversion Driven by Withdrawal Prevention, Abstinence Maintenance

USA. Research Summary: Buprenorphine Diversion Driven by Withdrawal Prevention, Abstinence Maintenance

 “Individuals who use diverted buprenorphine typically use it to prevent withdrawal symptoms or to maintain abstinence, according to research presented at the American Association of Nurse Practitioners 2018 National Conference.

Many users of diverted buprenorphine cited barriers to treatment access as a reason for not obtaining a prescription for the opioid partial agonist. Because recent legislation has extended buprenorphine waivers to qualified nurse practitioners and physician assistants, these clinicians may be able to help alleviate barriers to access. (Addiction Treatment Forum, USA, 09.07.2018)

http://atforum.com/2018/07/research-summary-buprenorphine-diversion-driven-by-withdrawal-prevention-abstinence-maintenance/